153 related articles for article (PubMed ID: 38140555)
1. From Infection to Malignancy: Tracing the Impact of Human Papillomavirus on Uterine Endometrial Cancer in a Nationwide Population-Based Cohort Study.
Wu PJ; Tsai SC; Huang JY; Lee MS; Wang PH; Lin FC
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140555
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States).
Hisada M; van den Berg BJ; Strickler HD; Christianson RE; Wright WE; Waters DJ; Rabkin CS
Cancer Causes Control; 2001 May; 12(4):335-41. PubMed ID: 11456229
[TBL] [Abstract][Full Text] [Related]
3. Comparison of human papillomavirus DNA levels in gynecological cancers: implication for cancer development.
Yang HJ; Liu VW; Tsang PC; Yip AM; Ng TY; Cheung AN; Ngan HY
Tumour Biol; 2003; 24(6):310-6. PubMed ID: 15004491
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of
Gautam H; Mehta S; Nayar N; Kumar N; Husain SA; Bharadwaj M
Syst Biol Reprod Med; 2023 Dec; 69(6):399-409. PubMed ID: 37668557
[TBL] [Abstract][Full Text] [Related]
5. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
Nelson RA; Lai LL
Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
[TBL] [Abstract][Full Text] [Related]
6. Maternal human papillomavirus infection and the risk of congenital malformations: A nationwide population-based cohort study.
Hsieh TYJ; Chen TYT; Liao PL; Huang JY; Ma KS; Hung YM; Chang R; Wei JC
J Med Virol; 2024 Apr; 96(4):e29549. PubMed ID: 38563352
[TBL] [Abstract][Full Text] [Related]
7. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.
Jensen KE; Thomsen LT; Schmiedel S; Frederiksen K; Norrild B; van den Brule A; Iftner T; Kjær SK
Sex Transm Infect; 2014 Nov; 90(7):550-5. PubMed ID: 24728044
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and sociodemographic predictors of high-risk vaginal human papillomavirus infection: findings from a public cervical cancer screening registry.
Jailani AS; Balqis-Ali NZ; Tang KF; Fun WH; Samad SA; Jahaya R; Subakir NN; Ismail R; Said ZM; Sararaks S
BMC Public Health; 2023 Nov; 23(1):2243. PubMed ID: 37964260
[TBL] [Abstract][Full Text] [Related]
9. Impact of cervical screening by human papillomavirus genotype: Population-based estimations.
Wang J; Elfström KM; Lagheden C; Eklund C; Sundström K; Sparén P; Dillner J
PLoS Med; 2023 Oct; 20(10):e1004304. PubMed ID: 37889928
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B
PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus infection in malignant and benign gynaecological conditions: a study in Greek women.
Konidaris S; Kouskouni EE; Panoskaltsis T; Kreatsas G; Patsouris ES; Sarivalassis A; Nonni A; Lazaris AC
Health Care Women Int; 2007 Feb; 28(2):182-91. PubMed ID: 17364979
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Human Papillomavirus Non-16/18, Type-Specific Risk for Cervical Intraepithelial Neoplasia Grade 3 or Worse Among Women With Cervical Atypical Glandular Cells.
Yilmaz E; Lagheden C; Ghaderi M; Wang J; Dillner J; Elfström KM
Obstet Gynecol; 2023 Sep; 142(3):679-687. PubMed ID: 37535949
[TBL] [Abstract][Full Text] [Related]
13. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
[TBL] [Abstract][Full Text] [Related]
14. The association between human papillomavirus infection and female lung cancer: A population-based cohort study.
Lin FC; Huang JY; Tsai SC; Nfor ON; Chou MC; Wu MF; Lee CT; Jan CF; Liaw YP
Medicine (Baltimore); 2016 Jun; 95(23):e3856. PubMed ID: 27281096
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
[TBL] [Abstract][Full Text] [Related]
16. The Prevalence of Genital Human Papillomavirus Subtypes in a Cohort of Hispanic Women Presenting for Cervical Cancer Screening Along the US-Mexico Border.
Shokar NK; Doan A; Calderon-Mora J; Lakshmanaswamy R; Ramadevi S; Shokar GS; Molokwu J; Alomari A; Dwivedi A
Cancer Control; 2020; 27(1):1073274820951780. PubMed ID: 32959673
[No Abstract] [Full Text] [Related]
17. Effect of Human Immunodeficiency Virus Infection on Human Papillomavirus Clearance Among Women in Senegal, West Africa.
Li Z; Winer RL; Ba S; Sy MP; Lin J; Feng Q; Gottlieb GS; Salif Sow P; Kiviat NB; Hawes SE
J Infect Dis; 2023 Apr; 227(9):1088-1096. PubMed ID: 36314598
[TBL] [Abstract][Full Text] [Related]
18. [Changes in genotype prevalence of human papillomavirus over 10-year follow-up of a cervical cancer screening cohort].
Dong L; Hu SY; Zhang Q; Feng RM; Zhang L; Zhao XL; Ma JF; Shi SD; Zhang X; Pan QJ; Zhang WH; Qiao YL; Zhao FH
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):20-25. PubMed ID: 28100371
[No Abstract] [Full Text] [Related]
19. [Human papillomavirus associated cervix uteri morbidity in Hungary: epidemiology and correlation with the HPV types and the simultaneous cytological diagnosis].
Szentirmay Z; Veleczki Z; Kásler M
Orv Hetil; 2017 Aug; 158(31):1213-1221. PubMed ID: 28758434
[TBL] [Abstract][Full Text] [Related]
20. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
